病态窦房结综合征综合危险因素分析:基于英国生物银行数据的遗传、社会人口学、临床与实验室研究
本研究利用英国生物银行405 869名38-73岁参与者,中位随访11.9年,评估社会人口学、临床、实验室及房颤多基因风险评分(PRS)对病态窦房结综合征(SSS)发病的预测价值。结果显示高龄、男性、既往心梗、高血压、高PRS及胱抑素C均与SSS风险升高相关,加入遗传和生物标志物后模型C-index由0.752升至0.760。
要点
- 房颤PRS高分位与SSS风险增加82%相关,中间分位增加32%。
- 胱抑素C升高与SSS风险增加相关(HR 1.71)。
- 加入遗传和生物标志物仅使预测模型C-index小幅提升。
核心结论
- 除社会人口学和临床危险因素外,房颤PRS和胱抑素C与SSS发病相关,其加入可小幅改善预测,提示整合遗传和生物标志物信息有助于SSS综合风险评估。
研究设计与样本
- 基于英国生物银行前瞻性队列,2006至2010年纳入22个中心502 421名38-73岁个体,排除数据不完整、既往房颤或瓣膜病后,最终分析405 869人(中位年龄58.0岁,IQR 50.0-64.0;男性213 684人,占45.2%)。
- 使用房颤PRS将参与者分为低危(第一五分位)、中危(中间三个五分位)和高危(第五五分位)三组,采用Cox回归评估社会人口学、临床、实验室及遗传变量与SSS发病的关联。
主要发现
- 中位随访11.9年期间共发生769例SSS事件。
- SSS发病率随年龄增长(每5年HR 1.52,95%CI 1.43-1.62)、男性(HR 1.39,95%CI 1.03-1.88)、既往心肌梗死(HR 1.54,95%CI 1.08-2.21)和高血压(HR 1.21,95%CI 1.02-1.42)而升高。
- 高PRS组和中间PRS组分别与SSS风险增加82%(HR 1.82,95%CI 1.45-2.29)和32%(HR 1.32,95%CI 1.07-1.62)相关。
- 胱抑素C与SSS风险增加相关(HR 1.71,95%CI 1.33-2.22)。
- 仅用社会人口学和临床变量的模型C-index为0.752,加入遗传和生物标志物数据后升至0.760。
临床怎么用
- 在评估SSS风险时,除传统临床因素外,可考虑结合房颤PRS和胱抑素C等生物标志物进行综合风险分层。
- 对于高龄、男性、有心肌梗死或高血压病史的患者,应关注SSS的发生风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sinoatrial node dysfunction and atrial fibrillation (AF) often coexist, and each potentially initiates or perpetuates the other. Consequently, genetic risk factors for AF may be associated with sick sinus syndrome (SSS). This study evaluated clinical, sociodemographic, laboratory and genetic factors in predicting the SSS incidence by using a polygenic risk score (PRS) for AF, given the absence of a dedicated PRS for SSS. METHODS: A total of 502 421 individuals aged 38-73 years across 22 centres from 2006 to 2010 were enrolled in the UK Biobank. After those with incomplete data, prior AF or valvular disease were excluded, 405 869 participants (median age 58.0 (IQR, 50.0-64.0) years; 213 684 (45.2%) male) were analysed. AF PRS categorised the participants into low (first quintile), intermediate (middle three quintiles) and high (fifth quintile) risks. SSS incidence was recorded, and associations were evaluated using Cox regression with sociodemographic, clinical, laboratory and genetic variables. RESULTS: During the median follow-up of 11.9 years, 769 SSS events occurred. Their incidence increased with age (HR 1.52, 95% CI 1.43 to 1.62 per 5 years), male sex (HR 1.39, 95% CI 1.03 to 1.88), prior myocardial infarction (HR 1.54, 95% CI 1.08 to 2.21) and hypertension (HR 1.21, 95% CI 1.02 to 1.42). The high-PRS and intermediate-PRS groups were related to 82% (HR 1.82, 95% CI 1.45 to 2.29) and 32% (HR 1.32, 95% CI 1.07 to 1.62) higher SSS risks, respectively. Cystatin C (HR 1.71, 95% CI 1.33 to 2.22) was also associated with the increased risk. The model's C-index was 0.752 with sociodemographic and clinical variables, but it increased to 0.760 with genetic and biomarker data. CONCLUSION: In addition to sociodemographic and clinical risk factors, AF PRS and cystatin C were linked to the SSS incidence. Although their inclusion modestly improved prediction, these findings highlighted the potential of integrating genetic and biomarker information for comprehensive SSS risk assessments.
引用
- Kim HJ, Yang PS, Park H, et al. Comprehensive risk factor analysis of sick sinus syndrome: a genetic, sociodemographic, clinical and laboratory investigation using the UK Biobank data. Heart. 2026. PMID: 41605626. doi:10.1136/heartjnl-2025-327272
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。